Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01241279 · ClinicalTrials.gov registry record · Phase 4

Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses

A Phase 4 study, sponsored by Bausch & Lomb Incorporated.

Terminated
Registry status
Phase 4
Development phase
6
Enrollment target

NCT01241279: Clinical Trial Phase 4 study, sponsored by Bausch & Lomb Incorporated.

NCT01241279 is a Phase 4 study that was terminated before completion, run by Bausch & Lomb Incorporated. The registered enrollment target is 6 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01241279, a Phase 4 study, was terminated before completion, sponsored by Bausch & Lomb Incorporated.

TERMINATED
Registry status
Phase 4
Development phase
6 participants
Enrollment target

Study Summary

The objective of this study is to demonstrate the correlation of near vision and changes in higher order aberrations following lens extraction and to characterize the defocus curves of Crystalens® AO™ intraocular lens (IOL) versus the monofocal aspheric SofPort® LI61AO IOL in adults.

Primary Outcome

The measurement of optical change in the power of the eye when viewing from far to near. Accommodation decreases as age increases resulting in an inability to focus on near objects.

Interventions

  • DEVICE Crystalens AO
  • DEVICE SoftPort LI61AO

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2010-10
Est. Completion 2011-12
Phase Phase 4
Bausch & Lomb Incorporated

174 total trials

Why NCT01241279 stopped before completion

NCT01241279 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Crystalens AO is the first listed.

NCT01241279 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01241279 about?

NCT01241279 is a clinical study titled "Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses". The objective of this study is to demonstrate the correlation of near vision and changes in higher order aberrations following lens extraction and to characterize the defocus curves of Crystalens® AO™ intraocular lens (IOL) versus the monofocal aspheric SofPort® LI61AO IOL in adults.

What is the current status of trial NCT01241279?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2010-10. Estimated completion is 2011-12.

What interventions are being tested in trial NCT01241279?

The interventions under investigation include: Crystalens AO (DEVICE), SoftPort LI61AO (DEVICE).

Who is sponsoring clinical trial NCT01241279?

This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01241279's enrollment target sits among peer trials

6 1983rd of 2000 higher than 12 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01241279, the US trial registry maintained by the National Library of Medicine. NCT01241279 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.